T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunityDaniela Schmid, Michael S. Goldberg|Nature Communications|2017Cited by 440
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancerChristina Hartl, Michael S. Goldberg|Journal for ImmunoTherapy of Cancer|2019Cited by 36